CPHI & PMEC Shenzhen combines pharmaceutical inputs and development services with the equipment needed to manufacture, analyse and package medicines. Ingredients, biotechnology, finished dosage, contract services and laboratory technologies therefore sit alongside processing machinery and packaging, while the Greater Bay Area setting gives the programme a stronger biotech, R&D and Asia-Pacific market orientation than a general medical-device fair.
The completed 2025 event was the second edition and recorded 669 exhibitors and 12,192 visitors, according to the organiser.